SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is currently facing intense community debate as investors weigh the firm's aggressive dilution strategy against the impact of recent Bitcoin price volatility and external macro pressures. Market participants are actively scrutinizing the company's high-leverage business model, with ongoing discussions polarized between those anticipating a major liquidation risk and others viewing the stock's recent weakness as a prime opportunity for accumulation.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors debate the impact of a short-seller report on its primary holdings and the company's delayed 10-K filing. Despite volatility and bearish pressure, the community remains divided, with many long-term holders viewing the pullback as a buying opportunity ahead of anticipated debt reduction and earnings results.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is capturing significant community attention as investors anticipate the upcoming presentation of long-term Week 40 Phase 3 data for its lead skin disease asset, sonelokimab. The broader conversation is heavily focused on the stock's potential for a best-in-class profile, ongoing institutional accumulation, and sustained speculation regarding a potential buyout.

FUST (Fusion token) is the companion token of FUSD - with tokenomics which mirror those of a typical cryptocurrency. FUST can be placed in the FUST Fusion Miner and used to mine free FUSD. FUST has tokenomics which mirror those of a typical cryptocurrency, and allows those Degens who buy into the FUSD philosophy - but who also enjoy the thrill of chasing fast green candles - to make their play within the structure of the FUSD ecosystem and benefit from the best of both worlds; the possibility of a fast ride upwards whilst earning a passive income paid in our appreciating stable token courtesy of their FUST bag.

FUST Token

$FUST is gaining momentum as investors highlight its role in a self-sustaining ecosystem that generates passive income through the $FUSD appreciating stablecoin. Community members are actively discussing the upcoming platform integrations and a large-scale reward distribution, positioning the token as a utility-focused alternative to stagnant market assets.

"What's Updog?" is a Community Led token.

UpDog

UpDog is generating significant buzz as community members rally behind the meme-themed token, frequently sharing its contract address and encouraging others to join through active engagement on social platforms. While supporters highlight the community's longevity and thematic humor, detractors have surfaced concerns regarding the project's legitimacy and volatility.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending as traders closely monitor technical resistance levels and potential catalysts, including March delivery reports and anticipation of upcoming quarterly earnings. Community sentiment is deeply divided between long-term investors highlighting structural battery-swap growth and short-term traders debating the impact of ongoing market volatility and institutional short positions.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is surging following the FDA approval of Empaveli for the treatment of rare kidney diseases, C3 glomerulopathy (C3G) and primary IC-MPGN. Investors and the community are actively discussing the broad label and potential revenue impact, as the approval effectively derisks the company and fuels renewed speculation regarding its future as a potential M&A target.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is facing a sharp sell-off driven by investor concerns over cyclical memory pricing, potential AI demand shifts following industry reports on efficiency, and broad semiconductor distribution. While the community is deeply polarizeddebating whether this is a structural re-rating or a manipulative short trapmany traders are actively monitoring the stock's failure to rebound alongside broader market rallies while watching for key support levels.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as the community highlights significant supply locks and a viral "positivity" content strategy ahead of the project's one-year anniversary. Supporters are rallying around the project's commitment to building and long-term conviction, frequently drawing comparisons to broader market movements and the "hopecore" sentiment.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is experiencing active community discussion centered on its pivot toward oncology and metabolic weight-loss therapies, with investors closely watching the company's efforts to offset post-pandemic revenue declines. While some sentiment remains cautious due to patent cliffs and management transitions, the community is actively debating the stock's potential for a long-term turnaround as it recovers from previous lows.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Axcelis Announces SBTi Approval of Science-Based Greenhouse Gas Emissions Reduction Targets

Axcelis Announces SBTi Approval of Science-Based Greenhouse Gas Emissions Reduction Targets Axcelis Announces SBTi Approval of Science-Based Greenhouse Gas Emissions Reduction Targets PR Newswire...

Axcelis Technologies (ACLS) Stock Moves -1.02%: What You Should Know

Axcelis Technologies (ACLS) closed the most recent trading day at $97.35, moving 1.02% from the previous trading session.

Axcelis Technologies Reaches Analyst Target Price

In recent trading, shares of Axcelis Technologies Inc (Symbol: ACLS) have crossed above the average analyst 12-month target price of $95.25, changing hands for $100.85/share. When a stock reaches the...

Axcelis Technologies (NASDAQ:ACLS) Trading Up 10.2%  - Should You Buy?

Axcelis Technologies (NASDAQ:ACLS) Shares Up 10.2% - Should You Buy...

Oliver Luxxe Assets LLC Invests $1.45 Million in Axcelis Technologies, Inc. $ACLS

Oliver Luxxe Assets LLC purchased a new position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 18,063 shares of the semiconductor company's stock...

Axcelis Technologies (ACLS) Gains As Market Dips: What You Should Know

In the latest trading session, Axcelis Technologies (ACLS) closed at $87.12, marking a +1.61% move from the previous day.

Axcelis Announces Participation in SEMICON China 2026

Axcelis Announces Participation in SEMICON China 2026 Axcelis Announces Participation in SEMICON China 2026 PR Newswire BEVERLY, Mass., March 19, 2026 President and CEO Russell Low will Present...

Axcelis Technologies, Inc. (NASDAQ:ACLS) Receives Consensus Rating of "Hold" from Analysts

Axcelis Technologies, Inc. (NASDAQ:ACLS - Get Free Report) has received an average recommendation of "Hold" from the six analysts that are presently covering the stock, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, two have given a hold rating and two have assign...

Axcelis Technologies, Inc. $ACLS Stake Lessened by Mizuho Markets Cayman LP

Mizuho Markets Cayman LP cut its stake in Axcelis Technologies, Inc. (NASDAQ:ACLS - Free Report) by 63.2% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and...

Axcelis Technologies, Inc. (NASDAQ:ACLS) Short Interest Down 25.9% in February

Axcelis Technologies, Inc. (NASDAQ:ACLS - Get Free Report) was the target of a significant drop in short interest in February. As of February 27th, there was short interest totaling 3,698,624 shares...

Axcelis Technologies Inc

Proxy filing

Axcelis Technologies, Inc. engages in the manufacture of capital equipment for the semiconductor chip manufacturing industry. Its ion implantation systems product line includes high and medium current, and energy implanters. It also offers post-sales equipment service and support, such as spare parts, equipment upgrades, used equipment, maintenance services, and customer training. The company was founded in 1978 and is headquartered in Beverly, MA.

iShares Dynamic Equity Active ETF ($BDYN)

Grayscale Bitcoin Trust ETF ($GBTC)

Destiny Tech100 Inc ($DXYZ)

Global X Defense Tech ETF ($SHLD)

The Modern Portfolio Builder. This award honors the fund that makes long-term investing easier, cheaper, or more effective for people who want to "set it and forget it."

Current Price	$90.94
Prev Close	$90.43
Open	$92.15
Dividend Yield	0.00%
50-Day Moving Average	$87.63
Beta	1.96
Avg. Volume	1.14M
PE Ratio	23.82

52-Week High	$102.93
52-Week Low	$40.40
Market Capitalization	$2.78B
EPS (Annual)	$3.80
Price to Book	2.68
Revenue Per Employee	$572,729.01

ACLS
Axcelis Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ACLS News

ACLSAxcelis Technologies Inc